Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

OBJECTIVE: To compare the incidence of anti-double-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor alpha (anti-TNFalpha) antibody or placebo infusions, with or without methotrexate, in open-...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Charles, P, Smeenk, R, De Jong, J, Feldmann, M, Maini, R
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2000

Eitemau Tebyg

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
gan: Elliot, M, et al.
Cyhoeddwyd: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
gan: Elliott, M, et al.
Cyhoeddwyd: (1993)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
gan: Paleolog, E, et al.
Cyhoeddwyd: (1996)

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
gan: Maini, R, et al.
Cyhoeddwyd: (1999)

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
gan: Elliott, M, et al.
Cyhoeddwyd: (1994)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
gan: Elliott, M, et al.
Cyhoeddwyd: (1994)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
gan: Maini, R, et al.
Cyhoeddwyd: (1999)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1994)

How does infliximab work in rheumatoid arthritis?
gan: Maini, R, et al.
Cyhoeddwyd: (2002)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
gan: Feldmann, M
Cyhoeddwyd: (1996)

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.
gan: Tak, P, et al.
Cyhoeddwyd: (1996)

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
gan: Maini, R, et al.
Cyhoeddwyd: (1998)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1997)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
gan: Brennan, F, et al.
Cyhoeddwyd: (1995)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
gan: Maini, R, et al.
Cyhoeddwyd: (1995)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
gan: Maini, R, et al.
Cyhoeddwyd: (1995)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1997)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
gan: Isaacs, J, et al.
Cyhoeddwyd: (1992)

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic.
gan: Taylor, P, et al.
Cyhoeddwyd: (1999)

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
gan: Lipsky, P, et al.
Cyhoeddwyd: (2000)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
gan: Isaacs, J, et al.
Cyhoeddwyd: (1992)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
gan: Brennan, F, et al.
Cyhoeddwyd: (1989)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
gan: Maini, R, et al.
Cyhoeddwyd: (1998)

Infliximab and methotrexate in the treatment of rheumatoid arthritis
gan: Lipsky, P, et al.
Cyhoeddwyd: (2000)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
gan: Kyle, V, et al.
Cyhoeddwyd: (1991)

Prospects of pharmacotherapy for rheumatoid arthritis: Monoclonal antibodies
gan: Evgeny Lvovich Nasonov, et al.
Cyhoeddwyd: (2012-06-01)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1995)

Perspectives of Quality of Life improvement in patients with rheumatoid arthritis with administration of fully human anti-tumor necrosis factor alpha monoclonal antibodies
gan: V N. Amirdjanova
Cyhoeddwyd: (2008-06-01)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
gan: Chu, C, et al.
Cyhoeddwyd: (1991)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
gan: Davis, D, et al.
Cyhoeddwyd: (1997)

Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.
gan: Butler, D, et al.
Cyhoeddwyd: (1995)

Miliary tuberculosis in a rheumatoid arthritis patient receiving long-term tumor necrosis factor monoclonal antibody therapy
gan: C.-R. Wang, et al.
Cyhoeddwyd: (2021-07-01)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
gan: Haworth, C, et al.
Cyhoeddwyd: (1991)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
gan: Paleolog, E, et al.
Cyhoeddwyd: (1998)

TNF alpha--a pivotal role in rheumatoid arthritis?
gan: Brennan, F, et al.
Cyhoeddwyd: (1992)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
gan: Maini, R, et al.
Cyhoeddwyd: (1994)

Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments
gan: Xiao-Kai Chi, et al.
Cyhoeddwyd: (2023-03-01)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
gan: Maini, R, et al.
Cyhoeddwyd: (1994)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
gan: Williams, R, et al.
Cyhoeddwyd: (2000)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (2001)